摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2-amino-5-methoxy-4-methyl-phenyl)cyclohexylmethanone | 916513-24-1

中文名称
——
中文别名
——
英文名称
(2-amino-5-methoxy-4-methyl-phenyl)cyclohexylmethanone
英文别名
(2-Amino-5-methoxy-4-methylphenyl)-cyclohexylmethanone
(2-amino-5-methoxy-4-methyl-phenyl)cyclohexylmethanone化学式
CAS
916513-24-1
化学式
C15H21NO2
mdl
——
分子量
247.337
InChiKey
ORRMPYJUFWUUNZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    393.1±37.0 °C(Predicted)
  • 密度:
    1.094±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.9
  • 重原子数:
    18
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.53
  • 拓扑面积:
    52.3
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    Discovery and Characterization of Novel, Potent, Non-Peptide Parathyroid Hormone-1 Receptor Antagonists
    摘要:
    A 1,3,4-benzotriazepine was identified as a suitable lead in our effort toward obtaining a non-peptide parathyroid hormone-1 receptor (PTHIR) antagonist. A process of optimization afforded derivatives displaying nanomolar PTHIR affinity, a representative example of which behaved as a PTHIR antagonist in cell-based cyclic adenosine monophosphate (cAMP) assays, with selectivity over PTH2 receptors.
    DOI:
    10.1021/jm0707626
  • 作为产物:
    描述:
    环己甲腈4-甲氧基-3-甲基苯胺三氯化硼三氯化铝盐酸 作用下, 以 甲苯 、 xylene 为溶剂, 反应 2.5h, 以25%的产率得到(2-amino-5-methoxy-4-methyl-phenyl)cyclohexylmethanone
    参考文献:
    名称:
    Discovery and Characterization of Novel, Potent, Non-Peptide Parathyroid Hormone-1 Receptor Antagonists
    摘要:
    A 1,3,4-benzotriazepine was identified as a suitable lead in our effort toward obtaining a non-peptide parathyroid hormone-1 receptor (PTHIR) antagonist. A process of optimization afforded derivatives displaying nanomolar PTHIR affinity, a representative example of which behaved as a PTHIR antagonist in cell-based cyclic adenosine monophosphate (cAMP) assays, with selectivity over PTH2 receptors.
    DOI:
    10.1021/jm0707626
点击查看最新优质反应信息

文献信息

  • [EN] BENZOTRIAZEPINONE DERIVATIVES<br/>[FR] DERIVES DE BENZOTRIAZEPINONE
    申请人:JAMES BLACK FOUNDATION
    公开号:WO2006129120A9
    公开(公告)日:2007-03-22
    [EN] The present invention is concerned with benzotriazepinone derivatives, their intermediates, uses thereof and processes for their production. In particular, the present invention relates to parathyroid hormone (PTH) and parathyroid hormone related protein (PTHrp) receptor ligands, (PTH-l or PTH/PTHrp receptor ligands). The invention also relates to methods of preparing such ligands and to compounds which are useful as intermediates in such methods.
    [FR] La présente invention concerne des dérivés de benzotriazépinone, leurs produits intermédiaires, leurs utilisations et des procédés pour leur production. Plus particulièrement, la présente invention concerne des ligands des récepteurs de l'hormone parathyroïdienne (PTH) et de la protéine apparentée à l'hormone parathyroïdienne (PTHrp) (ligands des récepteurs PTH-1 ou des récepteurs de la PTH/PTHrp). L'invention concerne également des procédés de préparation de ces ligands ainsi que des composés utiles comme produits intermédiaires dans ces procédés.
  • [EN] BENZOTRIAZEPINONE DERIVATIVES<br/>[FR] DÉRIVÉS DE BENZOTRIAZÉPINONE
    申请人:JAMES BLACK FOUNDATION
    公开号:WO2007135417A1
    公开(公告)日:2007-11-29
    [EN] The present invention is concerned with benzotriazepinone derivatives, their intermediates, uses thereof and processes for their production. In particular, the present invention relates to parathyroid hormone (PTH) and parathyroid hormone related protein (PTHrp) receptor ligands, (PTH-I or PTH/PTHrp receptor ligands). The invention also relates to methods of preparing such ligands and to compounds which are useful as intermediates in such methods.
    [FR] L'invention concerne des dérivés de benzotriazépinone, leurs intermédiaires, leurs utilisations et leurs procédés de production. En particulier, l'invention concerne une hormone parathyroïdienne (PTH) et des ligands de récepteurs de protéines associées à des hormones parathyroïdiennes (PTHrp) (ligands de récepteurs PTH-I ou PTH/PTHrp). L'invention concerne également des procédés de préparation de tels ligands et des composés utiles en tant qu'intermédiaires dans de tels procédés.
  • Discovery and Characterization of Novel, Potent, Non-Peptide Parathyroid Hormone-1 Receptor Antagonists
    作者:Iain M. McDonald、Carol Austin、Ildiko M. Buck、David J. Dunstone、John Gaffen、Eric Griffin、Elaine A. Harper、Robert A. D. Hull、S. Barret Kalindjian、Ian D. Linney、Caroline M. R. Low、Dipa Patel、Michael J. Pether、Michelle Raynor、Sonia P. Roberts、Mark E. Shaxted、John Spencer、Katherine I. M. Steel、David A. Sykes、Paul T. Wright、Wei Xun
    DOI:10.1021/jm0707626
    日期:2007.10.1
    A 1,3,4-benzotriazepine was identified as a suitable lead in our effort toward obtaining a non-peptide parathyroid hormone-1 receptor (PTHIR) antagonist. A process of optimization afforded derivatives displaying nanomolar PTHIR affinity, a representative example of which behaved as a PTHIR antagonist in cell-based cyclic adenosine monophosphate (cAMP) assays, with selectivity over PTH2 receptors.
查看更多